Seufert advised RHÖN-KLINIKUM AG on a share repurchase program of approx. 1.6 billion Euro. Seufert advised in a team with other advisers. By the share repurchase, which in this form was the first of its kind in Germany, the company initially repurchased its own shares in order to redeem them. The basic capital was thereby reduced accordingly.
By this measure, RHÖN-KLINIKUM AG passes on to the shareholders part of the approx. 3 billion Euro of the proceeds of the sale of 43 hospitals to the Fresenius Group, which took place at the beginning of the year. Seufert also advised on that transaction.